MOVIPREP® Versus PICOLAX® Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

May 31, 2006

Conditions
Colonoscopy
Interventions
DRUG

macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate

Split dose, 1-litre solution in the evening prior to colonoscopy and second dose in the morning prior to colonoscopy

DRUG

NA picosulfate magnesium citrate

150 ml solution before 8am on day prior to colonoscopy and 150ml solution 6 to 8 hours later.

Trial Locations (1)

OX3 9DU

John Radcliffe Hospital, Department of Gastroenterology, Endoscopy Unit, Headley Way, Headington, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Norgine

INDUSTRY